New search | Conferencedetail
Print view
 
 

Complement-based Drug Development Summit Europe

evvnt Platform / evvnt
Conference themes
The Complement-based Drug Development Summit Europe is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases.

Across 3 content-packed days, the field's thought leaders from GSK, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to.
Professional congress organizer (PCO)
Hanson Wade Ltd.
Notes
Speakers: Anna Schubart (Novartis), Andrea Tenner (University of California), Michael Holers (University of Colorado), Paul Morgan (Cardiff University), Eva-Maria Nichols (GlaxoSmithKline), Michael Kirschfink (University of Heidelberg)
 

Enquiries and Registration:

URLs: Booking: https://go.evvnt.com/169759-1 Brochure: https://go.evvnt.com/169759-2
Mr. William Latter
44 020 3141 8700
 
Categories
Internal Medicine
Languages
English
Congress fees
GBP 2.997,00
(Gold: Conference and 2 Workshops: GBP 2997, Silver: Conference and 1 Workshops: GBP 2598, Bronze: Conference only: GBP 1999, Workshop: GBP 599)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel: +44 0207 3230 450
hello@evvnt.com
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthCenter of ExcellenceÄrzte der WeltCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)European Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für Wien

Facebook

Give us your professional opinion

Start survey

Start survey